Goldman Sachs Reiterates Neutral Rating on Takeda Pharmaceutical (4502:JP) (TAK)

June 16, 2026 12:22 AM

Goldman Sachs analyst Akinori ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found